Back to User profile » Dr Hai-Jun Zhang
Papers published by Dr Hai-Jun Zhang:
Upregulated Expression of Actin-Like 6A is a Risk Factor Affecting the Prognosis of Pancreatic Cancer
Zhang Z, Guo H, Zhang H
Cancer Management and Research 2021, 13:9467-9475
Published Date: 30 December 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Improvement of Diagnostic Accuracy for Pancreatic Cancer with Serum Lactate Dehydrogenase
Wang X, Wang C, Zhang H
Cancer Management and Research 2021, 13:4879-4886
Published Date: 21 June 2021
Effect of Glucose Variability on Pancreatic Cancer Through Regulation of COL6A1
Yu Q, Zhang Z, Zhang H
Cancer Management and Research 2021, 13:1291-1298
Published Date: 11 February 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical Management of Risk of Radiation Pneumonia with Serum Markers During the Radiotherapy for Patients with Thoracic Malignant Tumors
Deng Y, Qiu T, Patel N, Zhou S, Xue T, Zhang H
Cancer Management and Research 2019, 11:10249-10256
Published Date: 5 December 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
Zhou S, Khanal S, Zhang H
Therapeutics and Clinical Risk Management 2019, 15:211-221
Published Date: 31 January 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of gefitinib as first- and second-line therapy for advanced lung adenocarcinoma patients with positive exon 21 or 19 del epidermal growth factor receptor mutation
Patel N, Wu P, Zhang H
Cancer Management and Research 2017, 9:243-248
Published Date: 28 June 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Three generations of epidermal growth factor receptor tyrosine kinase inhibitors developed to revolutionize the therapy of lung cancer
Zhang H
Drug Design, Development and Therapy 2016, 10:3867-3872
Published Date: 24 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Osimertinib making a breakthrough in lung cancer targeted therapy
Zhang H
OncoTargets and Therapy 2016, 9:5489-5493
Published Date: 6 September 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
Liu P, Zhang H, Wu X, Guo L, Wang F, Xia G, Chen B, Yin H, Wang Y, Li X
OncoTargets and Therapy 2016, 9:5049-5059
Published Date: 12 August 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
Zhang H, Chen R, Yang S, Liu W, Li K, Zhang H, Zhu X, Chen B
OncoTargets and Therapy 2016, 9:4215-4224
Published Date: 11 July 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Onivyde for the therapy of multiple solid tumors
Zhang H
OncoTargets and Therapy 2016, 9:3001-3007
Published Date: 20 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
Wu X, Zhang H, Salmani JMM, Fu R, Chen B
OncoTargets and Therapy 2016, 9:2935-2943
Published Date: 17 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Apatinib for molecular targeted therapy in tumor
Zhang H
Drug Design, Development and Therapy 2015, 9:6075-6081
Published Date: 13 November 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Urinary kallidinogenase for the treatment of cerebral arterial stenosis
Zhao L, Zhao Y, Wan Q, Zhang H
Drug Design, Development and Therapy 2015, 9:5595-5600
Published Date: 13 October 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
Guo L, Zhang H, Shao W, Chen B
Drug Design, Development and Therapy 2015, 9:5491-5497
Published Date: 3 October 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system
Guo L, Zhang H, Wang F, Liu P, Wang Y, Xia G, Liu R, Li X, Yin H, Jiang H, Chen B
International Journal of Nanomedicine 2015, 10:4535-4547
Published Date: 16 July 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of stent-assisted angioplasty on cognitive status and serum levels of amyloid beta in patients with intracranial and/or extracranial artery stenosis
Zhao L, Zhao Y, Zhang H
Neuropsychiatric Disease and Treatment 2015, 11:471-475
Published Date: 24 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes
![](cr_data/cache/submission_images/s74000/74962/figure_1_200_200_90.jpg)
Wu P, Li S, Zhang H
Drug Design, Development and Therapy 2014, 8:2431-2438
Published Date: 5 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics
Deng Y, Zhang H
International Journal of Nanomedicine 2013, 8:1835-1841
Published Date: 8 May 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Gambogic acid-loaded magnetic Fe3O4 nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1
Wang C, Zhang H, Chen Y, Shi F, Chen B
International Journal of Nanomedicine 2012, 7:781-787
Published Date: 14 February 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Daunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery system
Zhang H, Wang C, Chen B, Wang X
International Journal of Nanomedicine 2012, 7:235-242
Published Date: 12 January 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
Chen Y, Wan Y, Wang Y, Zhang H, Jiao Z
International Journal of Nanomedicine 2011, 6:2321-2326
Published Date: 18 October 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles
Wang C, Zhang H, Chen B, Yin H, Wang W
International Journal of Nanomedicine 2011, 6:1929-1935
Published Date: 9 September 2011